GL1X · GenesisL1 explorer

Research workbench

Crystal structure of leubat (DELTA13 mutant) in complex with sertraline

Analyse Crystal structure of leubat (DELTA13 mutant) in complex with sertraline in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MM5
Type
protein
Length
497 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transporter
UniProt
O67854
Ligands
SRE, NA
Pockets
6 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 78% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransporterprotein49778% helix, 1% strandO67854

Ligands and binding sites

  • SRE · (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15950.770.8355SRE
2970.550.8518empty
3890.470.8016empty
4930.350.7421empty
5610.340.7712empty

Compared structures

  • 4MM5 · Crystal structure of LeuBAT (delta13 mutant) in complex with sertraline · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.